INDUCTION OF SENESCENT CELL-DERIVED INHIBITOR OF DNA-SYNTHESIS GENE, SDI1, IN HEPATOBLASTOMA (HEPG2) CELLS ARRESTED IN THE G(2)-PHASE OF THE CELL-CYCLE BY 9-NITROCAMPTOTHECIN
Vi. Khaoustov et al., INDUCTION OF SENESCENT CELL-DERIVED INHIBITOR OF DNA-SYNTHESIS GENE, SDI1, IN HEPATOBLASTOMA (HEPG2) CELLS ARRESTED IN THE G(2)-PHASE OF THE CELL-CYCLE BY 9-NITROCAMPTOTHECIN, Laboratory investigation, 73(1), 1995, pp. 118-127
BACKGROUND: Recent studies have demonstrated that the plant-derived al
kaloid camptothecin (CPT) and its derivative, 9-nitro-CPT (9NC), are c
ytotoxic in tumorigenic cells but cytostatic in nontumorigenic cells i
n vitro and in vivo. Also, CPT induces differentiation of human leukem
ia cells in vitro along specific lineages. In this study, we have inve
stigated the effects of 9NC on nontumorigenic HepG2 cells derived from
human hepatoblastoma. A newly discovered senescent cell-derived inhib
itor (SDI1) plays a critical role in the cell cycle, so we evaluated t
he effect of 9NC on the expression of the SDI1 gene. EXPERIMENTAL, DES
IGN: The effects of 9NC on HepG2 cells were evaluated by monitoring DN
A synthesis, morphologic and ultrastructural changes of cells, and per
turbation in the cell cycle and by assessing the levels of p53 protein
and SDI1 mRNA. RESULTS: Treatment of HepG2 cells with 9NC results in
a dose-dependent inhibition of cell proliferation and DNA synthesis. F
low cytometric analysis of DNA content showed that SNC-treated HepG2 c
ells are arrested in the G(2)-phase of the cell cycle. Light and elect
ron microscopic examination revealed that 9NC at low concentrations in
duces morphologic and growth features that resemble properties highly
differentiated or senescent cells, i.e., increased cell size and decre
ased nuclear/cytoplasmic ratio, as well as enlarged numbers of lysosom
es, mitochondria, and Lipid in the cytoplasm. No significant alteratio
n in the p53 protein level was noted in SNC-treated cells. In contrast
to untreated, logarithmically grown HepG2 cells, SNC-treated cells ar
rested at the G(2)-phase of the cell cycle and contained increased lev
els of SDI1 mRNA. Kinetic studies revealed gradual increases in SDI1 m
RNA synthesis. CONCLUSIONS: Induction of SDI1 mRNA by 9NC represents t
he first documentation that the SDI1 gene can be overexpressed in the
G(2)-phase of the cell cycle and provides a valuable cell culture syst
em to dissect the events controlling the G(2) checkpoint. In addition,
this finding corroborates the hypothesis that genes up-regulated in s
enescent cells can also be induced in tumor-derived immortalized cells
.